New-Onset Resistant Hypertension in a Newly Diagnosed Prostate Cancer Patient

Keyphrases

• New Onset 100%
• Prostate Cancer Patients 100%
• Newly Diagnosed 100%
• Plasma Renin Activity 100%
• Aldosterone 100%
• Resistant Hypertension 100%
• Ectopic Adrenocorticotropic Hormone Syndrome 66%
• Mineralocorticoid Excess 66%
• Older Men 33%
• Prostate Cancer 33%
• Blood Pressure 33%
• Neuroendocrine Prostate Cancer 33%
• Stable Patients 33%
• Rare Cause 33%
• Hormonal Control 33%
• Prostate Carcinoma 33%
• Diuretics 33%
• Antihypertensive Drugs 33%
• Common Cause 33%
• Hypokalemia 33%
• Rare Forms 33%
• Electrolyte Abnormalities 33%
• Antihypertensive Medication 33%
• Metabolic Alkalosis 33%
• Prostate Gland 33%
• Symptomatic Control 33%
• Hyperaldosteronism 33%
• Cushingoid 33%
• Bilateral Adrenalectomy 33%
• Hypercortisolism 33%
• Secondary Hyperaldosteronism 33%
• Small Cell Neuroendocrine Carcinoma 33%
• Chronic Hypertension 33%
• Secondary Causes 33%

Medicine and Dentistry

• Prostate Cancer 100%
• Resistant Hypertension 100%
• Renin 100%
• Aldosterone 100%
• Antihypertensive Agent 66%
• Corticotropin 66%
• Mineralocorticoid 66%
• Malignant Neoplasm 33%
• Blood Pressure 33%
• Adrenalectomy 33%
• Metabolic Alkalosis 33%
• Hypokalemia 33%
• Hyperaldosteronism 33%
• Neuroendocrine Carcinoma 33%
• Hypercortisolism 33%
• Diuretics 33%